Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.96
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
7.05
+0.09 (1.29%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Aura Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -106.19 | -86.92 | -76.41 | -58.76 | -35.25 | |
| Depreciation & Amortization | 1.13 | 1.22 | 1.3 | 1.18 | 0.83 | |
| Loss (Gain) From Sale of Assets | - | - | 0.21 | -0.02 | 0 | |
| Loss (Gain) From Sale of Investments | -1.55 | -4.66 | -3.99 | -0.53 | - | |
| Stock-Based Compensation | 14.32 | 11.72 | 8.77 | 6.41 | 2.31 | |
| Other Operating Activities | 1.58 | 1.47 | 1.84 | 0.97 | 0.02 | |
| Change in Accounts Payable | -0.85 | 0.48 | -1.04 | 0.34 | 1.05 | |
| Change in Other Net Operating Assets | 6.82 | -3.12 | 5.48 | -4.19 | -1.37 | |
| Operating Cash Flow | -84.74 | -79.81 | -63.85 | -54.6 | -32.41 | |
| Capital Expenditures | -0.45 | -1.25 | -0.71 | -1.09 | -2.13 | |
| Investment in Securities | 36.04 | 70.07 | -113.25 | -66.78 | - | |
| Investing Cash Flow | 35.6 | 68.82 | -113.96 | -67.87 | -2.13 | |
| Issuance of Common Stock | 53.75 | 1.6 | 97.29 | 95.63 | 79.05 | |
| Other Financing Activities | 23.41 | - | - | - | -0.02 | |
| Financing Cash Flow | 77.16 | 1.6 | 97.29 | 95.63 | 166.26 | |
| Foreign Exchange Rate Adjustments | -0.19 | - | - | - | - | |
| Net Cash Flow | 27.82 | -9.39 | -80.52 | -26.84 | 131.72 | |
| Free Cash Flow | -85.19 | -81.06 | -64.56 | -55.7 | -34.54 | |
| Free Cash Flow Per Share | -1.41 | -1.63 | -1.63 | -1.86 | -6.69 | |
| Cash Income Tax Paid | 0.1 | 0.1 | - | - | - | |
| Levered Free Cash Flow | -48.09 | -50.17 | -39.34 | -33.69 | -20.52 | |
| Unlevered Free Cash Flow | -48.09 | -50.17 | -39.34 | -33.69 | -20.52 | |
| Change in Working Capital | 5.97 | -2.64 | 4.44 | -3.85 | -0.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.